Abstract: The present invention relates to use of a compound of chemical formula 1 or a pharmaceutically acceptable salt thereof as a selective agonist of the melanocortin-4-receptor (MC4R).
| # | Name | Date |
|---|---|---|
| 1 | 202317045689-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [07-07-2023(online)].pdf | 2023-07-07 |
| 2 | 202317045689-STATEMENT OF UNDERTAKING (FORM 3) [07-07-2023(online)].pdf | 2023-07-07 |
| 3 | 202317045689-REQUEST FOR EXAMINATION (FORM-18) [07-07-2023(online)].pdf | 2023-07-07 |
| 4 | 202317045689-POWER OF AUTHORITY [07-07-2023(online)].pdf | 2023-07-07 |
| 5 | 202317045689-FORM 18 [07-07-2023(online)].pdf | 2023-07-07 |
| 6 | 202317045689-FORM 1 [07-07-2023(online)].pdf | 2023-07-07 |
| 7 | 202317045689-DRAWINGS [07-07-2023(online)].pdf | 2023-07-07 |
| 8 | 202317045689-DECLARATION OF INVENTORSHIP (FORM 5) [07-07-2023(online)].pdf | 2023-07-07 |
| 9 | 202317045689-COMPLETE SPECIFICATION [07-07-2023(online)].pdf | 2023-07-07 |
| 10 | 202317045689-Proof of Right [07-12-2023(online)].pdf | 2023-12-07 |
| 11 | 202317045689-FORM 3 [07-12-2023(online)].pdf | 2023-12-07 |
| 12 | 202317045689-FER.pdf | 2025-03-24 |
| 13 | 202317045689-FORM 3 [26-05-2025(online)].pdf | 2025-05-26 |
| 1 | 202317045689_SearchStrategyNew_E_SearchHistoryE_26-02-2025.pdf |